What is Brookdale Sr Living Inc's earnings per share (EPS)?

Brookdale Sr Living Inc (BKD) reported diluted earnings per share of $-1.12 for fiscal year 2025. This represents a -25.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Brookdale Sr Living Inc Financials

BKD

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Brookdale Sr Living Inc (BKD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 25/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Brookdale Sr Living Inc has an operating margin of 0.4%, meaning the company retains $0 of operating profit per $100 of revenue. This below-average margin results in a low score of 23/100, suggesting thin profitability after operating expenses. This is down from 1.5% the prior year.

Growth

Brookdale Sr Living Inc's revenue grew a modest 2.2% year-over-year to $3.2B. This slow but positive growth earns a score of 37/100.

Liquidity

Brookdale Sr Living Inc's current ratio of 0.98 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 14/100, which could limit financial flexibility.

Cash Flow

While Brookdale Sr Living Inc generated $218.0M in operating cash flow, capex of $201.5M consumed most of it, leaving $16.5M in free cash flow. This results in a low score of 26/100, reflecting heavy capital investment rather than weak cash generation.

Altman Z-Score Distress

-0.14

Brookdale Sr Living Inc scores -0.14, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.3B) relative to total liabilities ($6.0B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

5/9

Brookdale Sr Living Inc passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-0.83x

For every $1 of reported earnings, Brookdale Sr Living Inc generates $-0.83 in operating cash flow ($218.0M OCF vs -$262.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.2B

YoY+2.2%

5Y CAGR-2.0%

10Y CAGR-4.3%

Brookdale Sr Living Inc generated $3.2B in revenue in fiscal year 2025. This represents an increase of 2.2% from the prior year.

EBITDA

$383.8M

YoY-7.3%

5Y CAGR+7.5%

10Y CAGR-3.9%

Brookdale Sr Living Inc's EBITDA was $383.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.3% from the prior year.

Net Income

-$262.7M

YoY-30.1%

Brookdale Sr Living Inc reported -$262.7M in net income in fiscal year 2025. This represents a decrease of 30.1% from the prior year.

EPS (Diluted)

$-1.12

YoY-25.8%

Brookdale Sr Living Inc earned $-1.12 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 25.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$16.5M

YoY+147.1%

5Y CAGR-3.6%

Brookdale Sr Living Inc generated $16.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 147.1% from the prior year.

Cash & Debt

$279.1M

YoY-9.6%

5Y CAGR-6.0%

10Y CAGR+12.2%

Brookdale Sr Living Inc held $279.1M in cash against $4.2B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

238M

YoY+18.9%

5Y CAGR+4.8%

10Y CAGR+2.5%

Brookdale Sr Living Inc had 238M shares outstanding in fiscal year 2025. This represents an increase of 18.9% from the prior year.

Margins & Returns

Gross Margin

26.2%

YoY+0.7pp

5Y CAGR+3.7pp

10Y CAGR-3.0pp

Brookdale Sr Living Inc's gross margin was 26.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the prior year.

Operating Margin

0.4%

YoY-1.1pp

5Y CAGR+3.2pp

10Y CAGR+3.8pp

Brookdale Sr Living Inc's operating margin was 0.4% in fiscal year 2025, reflecting core business profitability. This is down 1.1 percentage points from the prior year.

Net Margin

-8.2%

YoY-1.8pp

5Y CAGR-10.5pp

10Y CAGR+1.0pp

Brookdale Sr Living Inc's net profit margin was -8.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.8 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$201.5M

YoY+0.1%

5Y CAGR+1.6%

10Y CAGR-6.9%

Brookdale Sr Living Inc invested $201.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.1% from the prior year.

BKD Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.2B+2.2%	$3.1B+3.6%	$3.0B+6.7%	$2.8B+2.4%	$2.8B-22.1%	$3.5B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$837.5M+4.8%	$799.3M+7.0%	$746.7M+25.6%	$594.4M+18.7%	$501.0M-37.2%	$797.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$195.1M+5.0%	$185.8M+3.9%	$178.9M+6.1%	$168.6M-8.8%	$184.9M-10.5%	$206.6M
Operating Income	$13.5M-71.0%	$46.5M+152.7%	$18.4M+143.1%	-$42.7M+80.3%	-$216.9M-122.1%	-$97.7M
Interest Expense	N/A	$252.6M+6.0%	$238.3M+16.4%	$204.7M+4.9%	$195.1M-6.5%	$208.8M
Income Tax	-$2.0M-142.0%	$4.6M-47.1%	$8.8M+663.4%	-$1.6M+80.9%	-$8.2M-252.5%	$5.4M
Net Income	-$262.7M-30.1%	-$201.9M-6.8%	-$189.0M+20.7%	-$238.4M-140.1%	-$99.3M-221.1%	$82.0M
EPS (Diluted)	$-1.12-25.8%	$-0.89-6.0%	$-0.84+32.8%	$-1.25-131.5%	$-0.54-222.7%	$0.44

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$754.1M-7.3%	$813.2M0.0%	$812.9M-0.1%	$813.9M+4.2%	$780.9M-0.4%	$784.2M+0.9%	$777.5M-0.7%	$782.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$187.7M-11.0%	$210.9M-2.3%	$215.9M-3.2%	$223.1M+16.2%	$192.1M-3.1%	$198.1M-3.3%	$204.8M+0.2%	$204.3M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$41.4M-18.6%	$50.9M-7.5%	$55.0M+14.8%	$47.9M-1.3%	$48.5M+8.0%	$44.9M-3.7%	$46.7M+2.0%	$45.7M
Operating Income	$22.9M+142.4%	-$53.8M-461.1%	$14.9M-49.6%	$29.6M+1482.7%	-$2.1M-120.8%	$10.3M-46.5%	$19.2M-0.4%	$19.2M
Interest Expense	N/A	$63.6M+0.8%	$63.1M-3.0%	$65.0M-2.9%	$67.0M+1.0%	$66.3M+7.7%	$61.6M+6.7%	$57.7M
Income Tax	-$1.2M-801.2%	$167K+161.6%	-$271K+59.9%	-$676K-119.0%	$3.6M+425.8%	$677K+50.8%	$449K+1222.5%	-$40K
Net Income	-$40.0M+65.2%	-$114.7M-166.7%	-$43.0M+33.8%	-$65.0M+22.6%	-$83.9M-65.5%	-$50.7M-34.4%	-$37.7M-27.6%	-$29.6M
EPS (Diluted)	N/A	$-0.48-166.7%	$-0.18+35.7%	$-0.28	N/A	$-0.22-29.4%	$-0.17-30.8%	$-0.13

BKD Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$6.0B-6.1%	$6.3B+13.7%	$5.6B-6.1%	$5.9B-7.4%	$6.4B-7.1%	$6.9B
Current Assets	$553.9M+8.0%	$512.9M+7.2%	$478.4M-24.9%	$637.1M-8.9%	$699.0M-9.6%	$773.6M
Cash & Equivalents	$279.1M-9.6%	$308.9M+11.1%	$278.0M-30.3%	$398.9M+14.9%	$347.0M-8.8%	$380.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$67.7M+30.4%	$51.9M+7.2%	$48.4M-13.2%	$55.8M+9.0%	$51.1M-53.2%	$109.2M
Goodwill	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M-82.3%	$154.1M
Total Liabilities	$6.0B-2.1%	$6.1B+18.4%	$5.2B-3.4%	$5.4B-6.3%	$5.7B-6.4%	$6.1B
Current Liabilities	$567.9M-2.0%	$579.8M-3.4%	$600.1M-6.4%	$641.2M+1.5%	$632.0M-8.5%	$690.7M
Long-Term Debt	$4.2B+4.8%	$4.0B+10.0%	$3.7B-3.4%	$3.8B+0.2%	$3.8B-1.8%	$3.8B
Total Equity	-$44.8M-121.1%	$212.5M-47.4%	$403.7M-30.7%	$582.6M-16.5%	$697.4M-12.9%	$800.4M
Retained Earnings	-$4.3B-6.5%	-$4.0B-5.3%	-$3.8B-5.2%	-$3.6B-7.0%	-$3.4B-3.0%	-$3.3B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$6.0B-1.0%	$6.0B-2.1%	$6.1B-1.0%	$6.2B-2.0%	$6.3B+6.7%	$5.9B+9.0%	$5.5B-1.6%	$5.5B
Current Assets	$553.9M+3.2%	$536.9M+14.9%	$467.5M+3.0%	$454.0M-11.5%	$512.9M+8.3%	$473.7M-3.9%	$492.8M-4.4%	$515.7M
Cash & Equivalents	$279.1M+10.1%	$253.4M+0.6%	$251.9M+5.1%	$239.7M-22.4%	$308.9M+21.3%	$254.7M-12.2%	$290.0M-9.0%	$318.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$67.7M+0.2%	$67.6M+20.5%	$56.1M-3.2%	$57.9M+11.6%	$51.9M-2.1%	$53.0M+6.5%	$49.8M+0.3%	$49.6M
Goodwill	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M0.0%	$27.3M
Total Liabilities	$6.0B-0.4%	$6.0B-0.3%	$6.0B-0.4%	$6.1B-1.0%	$6.1B+8.4%	$5.6B+10.5%	$5.1B-1.1%	$5.2B
Current Liabilities	$567.9M-11.0%	$637.8M+12.7%	$565.7M+1.8%	$555.7M-4.1%	$579.8M-0.7%	$584.0M-6.1%	$622.1M+1.3%	$614.3M
Long-Term Debt	$4.2B+1.3%	$4.2B-1.7%	$4.2B-0.4%	$4.2B+5.6%	$4.0B+10.1%	$3.7B-0.7%	$3.7B-0.4%	$3.7B
Total Equity	-$44.8M-564.9%	-$6.7M-106.4%	$105.4M-28.2%	$146.7M-30.9%	$212.5M-27.5%	$292.9M-13.9%	$340.2M-9.0%	$374.0M
Retained Earnings	-$4.3B-0.9%	-$4.3B-2.8%	-$4.1B-1.0%	-$4.1B-1.6%	-$4.0B-2.1%	-$4.0B-1.3%	-$3.9B-1.0%	-$3.9B

BKD Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$218.0M+31.2%	$166.2M+2.0%	$162.9M+4865.7%	$3.3M+103.5%	-$94.6M-146.0%	$205.6M
Capital Expenditures	$201.5M+0.1%	$201.3M-13.7%	$233.2M+18.4%	$196.9M+11.5%	$176.7M-5.0%	$185.9M
Free Cash Flow	$16.5M+147.1%	-$35.1M+50.1%	-$70.3M+63.7%	-$193.6M+28.6%	-$271.3M-1471.7%	$19.8M
Investing Cash Flow	-$456.0M-64.0%	-$278.1M-145.3%	-$113.4M-68.1%	-$67.4M-137.2%	$181.5M+142.7%	-$425.1M
Financing Cash Flow	$201.1M+41.6%	$142.1M+181.4%	-$174.4M-273.8%	$100.4M+188.3%	-$113.7M-129.7%	$382.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	$0	$0-100.0%	$18.1M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$34.5M-54.9%	$76.5M-8.4%	$83.6M+257.1%	$23.4M-48.2%	$45.2M-32.0%	$66.5M+19.4%	$55.7M+4957.8%	-$1.1M
Capital Expenditures	$63.7M+53.1%	$41.6M-23.6%	$54.5M+30.2%	$41.8M-16.9%	$50.3M-8.5%	$55.0M+6.6%	$51.6M+16.2%	$44.4M
Free Cash Flow	-$29.1M-183.3%	$34.9M+20.1%	$29.1M+258.0%	-$18.4M-260.1%	-$5.1M-144.5%	$11.5M+180.5%	$4.1M+109.0%	-$45.5M
Investing Cash Flow	-$44.6M-30.4%	-$34.2M+32.2%	-$50.4M+84.6%	-$326.8M-126.0%	-$144.6M-148.7%	-$58.1M+15.1%	-$68.5M-885.6%	-$6.9M
Financing Cash Flow	$21.7M+162.9%	-$34.6M-34.2%	-$25.8M-110.7%	$239.7M+62.9%	$147.1M+479.2%	-$38.8M-90.4%	-$20.4M-137.7%	$54.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BKD Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	26.2%+0.7pp	25.6%+0.8pp	24.8%+3.7pp	21.0%+2.9pp	18.2%-4.4pp	22.5%
Operating Margin	0.4%-1.1pp	1.5%+0.9pp	0.6%+2.1pp	-1.5%+6.3pp	-7.9%-5.1pp	-2.8%
Net Margin	-8.2%-1.8pp	-6.5%-0.2pp	-6.3%+2.2pp	-8.4%-4.8pp	-3.6%-5.9pp	2.3%
Return on Equity	N/A	-95.0%-48.2pp	-46.8%-5.9pp	-40.9%-26.7pp	-14.2%-24.5pp	10.3%
Return on Assets	-4.4%-1.2pp	-3.2%+0.2pp	-3.4%+0.6pp	-4.0%-2.5pp	-1.6%-2.7pp	1.2%
Current Ratio	0.98+0.1	0.88+0.1	0.80-0.2	0.99-0.1	1.11-0.0	1.12
Debt-to-Equity	-94.18-113.1	18.93+9.9	9.06+2.6	6.50+1.1	5.42+0.6	4.81
FCF Margin	0.5%+1.6pp	-1.1%+1.2pp	-2.3%+4.5pp	-6.9%+3.0pp	-9.8%-10.4pp	0.6%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	24.9%-1.0pp	25.9%-0.6pp	26.6%-0.9pp	27.4%+2.8pp	24.6%-0.7pp	25.3%-1.1pp	26.3%+0.2pp	26.1%
Operating Margin	3.0%+9.7pp	-6.6%-8.4pp	1.8%-1.8pp	3.6%+3.9pp	-0.3%-1.6pp	1.3%-1.1pp	2.5%0.0pp	2.5%
Net Margin	-5.3%+8.8pp	-14.1%-8.8pp	-5.3%+2.7pp	-8.0%+2.8pp	-10.8%-4.3pp	-6.5%-1.6pp	-4.9%-1.1pp	-3.8%
Return on Equity	N/A	N/A	-40.8%+3.5pp	-44.3%-4.8pp	-39.5%-22.2pp	-17.3%-6.2pp	-11.1%-3.2pp	-7.9%
Return on Assets	-0.7%+1.2pp	-1.9%-1.2pp	-0.7%+0.4pp	-1.1%+0.3pp	-1.3%-0.5pp	-0.9%-0.2pp	-0.7%-0.2pp	-0.5%
Current Ratio	0.98+0.1	0.84+0.0	0.830.0	0.82-0.1	0.88+0.1	0.81+0.0	0.79-0.0	0.84
Debt-to-Equity	-94.18+523.8	-617.94-658.1	40.16+11.2	28.96+10.0	18.93+6.5	12.48+1.7	10.81+0.9	9.87
FCF Margin	-3.9%-8.2pp	4.3%+0.7pp	3.6%+5.8pp	-2.3%-1.6pp	-0.7%-2.1pp	1.5%+0.9pp	0.5%+6.3pp	-5.8%

Note: Shareholder equity is negative (-$44.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.98), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

National Health NHC

$2.5B

Ardent Health ARDT

$1.2B

Aveanna Healthcare Holdings, Inc. AVAH

$1.4B

P3 HEALTH PARTNERS INC PIII

$8.5M

Guardian Pharmacy Services, Inc. GRDN

$2.4B

Frequently Asked Questions

What is Brookdale Sr Living Inc's annual revenue?

Brookdale Sr Living Inc (BKD) reported $3.2B in total revenue for fiscal year 2025. This represents a 2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Brookdale Sr Living Inc's revenue growing?

Brookdale Sr Living Inc (BKD) revenue grew by 2.2% year-over-year, from $3.1B to $3.2B in fiscal year 2025.

Is Brookdale Sr Living Inc profitable?

No, Brookdale Sr Living Inc (BKD) reported a net income of -$262.7M in fiscal year 2025, with a net profit margin of -8.2%.

What is Brookdale Sr Living Inc's EBITDA?

Brookdale Sr Living Inc (BKD) had EBITDA of $383.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Brookdale Sr Living Inc have?

As of fiscal year 2025, Brookdale Sr Living Inc (BKD) had $279.1M in cash and equivalents against $4.2B in long-term debt.

What is Brookdale Sr Living Inc's gross margin?

Brookdale Sr Living Inc (BKD) had a gross margin of 26.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Brookdale Sr Living Inc's operating margin?

Brookdale Sr Living Inc (BKD) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Brookdale Sr Living Inc's net profit margin?

Brookdale Sr Living Inc (BKD) had a net profit margin of -8.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Brookdale Sr Living Inc's free cash flow?

Brookdale Sr Living Inc (BKD) generated $16.5M in free cash flow during fiscal year 2025. This represents a 147.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Brookdale Sr Living Inc's operating cash flow?

Brookdale Sr Living Inc (BKD) generated $218.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Brookdale Sr Living Inc's total assets?

Brookdale Sr Living Inc (BKD) had $6.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Brookdale Sr Living Inc's capital expenditures?

Brookdale Sr Living Inc (BKD) invested $201.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Brookdale Sr Living Inc have outstanding?

Brookdale Sr Living Inc (BKD) had 238M shares outstanding as of fiscal year 2025.

What is Brookdale Sr Living Inc's current ratio?

Brookdale Sr Living Inc (BKD) had a current ratio of 0.98 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Brookdale Sr Living Inc's debt-to-equity ratio?

Brookdale Sr Living Inc (BKD) had a debt-to-equity ratio of -94.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Brookdale Sr Living Inc's return on assets (ROA)?

Brookdale Sr Living Inc (BKD) had a return on assets of -4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Brookdale Sr Living Inc's debt-to-equity ratio negative or unusual?

Brookdale Sr Living Inc (BKD) has negative shareholder equity of -$44.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Brookdale Sr Living Inc's Altman Z-Score?

Brookdale Sr Living Inc (BKD) has an Altman Z-Score of -0.14, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Brookdale Sr Living Inc's Piotroski F-Score?

Brookdale Sr Living Inc (BKD) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Brookdale Sr Living Inc's earnings high quality?

Brookdale Sr Living Inc (BKD) has an earnings quality ratio of -0.83x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Brookdale Sr Living Inc?

Brookdale Sr Living Inc (BKD) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.